Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity.
Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity.
复制标题
DOI:
10.1038/s41386-022-01277-6
复制
发表时间:
2022-06
影响因子:
7.6
通讯作者:
Mellor, Jack R.
中科院分区:
文献类型:
--
作者:
Griesius, Simonas;O'Donnell, Cian;Waldron, Sophie;Thomas, Kerrie L.;Dwyer, Dominic M.;Wilkinson, Lawrence S.;Hall, Jeremy;Robinson, Emma S. J.;Mellor, Jack R.
Copy number variants indicating loss of function in the DLG2 gene have been associated with markedly increased risk for schizophrenia, autism spectrum disorder, and intellectual disability. DLG2 encodes the postsynaptic scaffolding protein DLG2 (PSD93) that interacts with NMDA receptors, potassium channels, and cytoskeletal regulators but the net impact of these interactions on synaptic plasticity, likely underpinning cognitive impairments associated with these conditions, remains unclear. Here, hippocampal CA1 neuronal excitability and synaptic function were investigated in a novel clinically relevant heterozygous Dlg2+/− rat model using ex vivo patch-clamp electrophysiology, pharmacology, and computational modelling. Dlg2+/− rats had reduced supra-linear dendritic integration of synaptic inputs resulting in impaired associative long-term potentiation. This impairment was not caused by a change in synaptic input since NMDA receptor-mediated synaptic currents were, conversely, increased and AMPA receptor-mediated currents were unaffected. Instead, the impairment in associative long-term potentiation resulted from an increase in potassium channel function leading to a decrease in input resistance, which reduced supra-linear dendritic integration. Enhancement of dendritic excitability by blockade of potassium channels or activation of muscarinic M1 receptors with selective allosteric agonist 77-LH-28-1 reduced the threshold for dendritic integration and 77-LH-28-1 rescued the associative long-term potentiation impairment in the Dlg2+/− rats. These findings demonstrate a biological phenotype that can be reversed by compound classes used clinically, such as muscarinic M1 receptor agonists, and is therefore a potential target for therapeutic intervention.
登录
查看更多内容
DOI:
10.1186/s13195-021-00816-5
发表时间:
2021-04-21
期刊:
Alzheimer's research & therapy
影响因子:
--
作者:
Bakker C;Tasker T;Liptrot J;Hart EP;Klaassen ES;Doll RJ;Brown GA;Brown A;Congreve M;Weir M;Marshall FH;Cross DM;Groeneveld GJ;Nathan PJ
通讯作者:
Nathan PJ
影响因子:
16.2
作者:
Elias, Guillermo M.;Funke, Lars;Nicoll, Roger A.
通讯作者:
Nicoll, Roger A.
影响因子:
4.7
作者:
Dakoji, S;Tomita, S;Bredt, DS
通讯作者:
Bredt, DS
DOI:
10.1093/cercor/bhv227
发表时间:
2016-01
期刊:
Cerebral cortex (New York, N.Y. : 1991)
影响因子:
--
作者:
Dennis SH;Pasqui F;Colvin EM;Sanger H;Mogg AJ;Felder CC;Broad LM;Fitzjohn SM;Isaac JT;Mellor JR
通讯作者:
Mellor JR
影响因子:
2.2
作者:
Egger, Gerald;Roetzer, Katharina M.;Vincent, John B.
通讯作者:
Vincent, John B.